A detailed history of Neos Investment Management LLC transactions in Crinetics Pharmaceuticals, Inc. stock. As of the latest transaction made, Neos Investment Management LLC holds 57,389 shares of CRNX stock, worth $3.1 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares
57,389
Previous 53,570 7.13%
Holding current value
$3.1 Million
Previous $2.4 Billion 22.22%
% of portfolio
0.09%
Previous 0.1%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$43.83 - $54.98 $167,386 - $209,968
3,819 Added 7.13%
57,389 $2.93 Billion
Q2 2024

Aug 14, 2024

BUY
$42.12 - $51.91 $552,656 - $681,111
13,121 Added 32.44%
53,570 $2.4 Billion
Q1 2024

May 13, 2024

BUY
$34.76 - $46.81 $937,407 - $1.26 Million
26,968 Added 200.04%
40,449 $1.89 Billion
Q4 2023

Feb 13, 2024

BUY
$25.62 - $37.07 $345,383 - $499,740
13,481 New
13,481 $480 Million

Others Institutions Holding CRNX

About Crinetics Pharmaceuticals, Inc.


  • Ticker CRNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 53,752,800
  • Market Cap $2.9B
  • Description
  • Crinetics Pharmaceuticals, Inc., a clinical stage pharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for rare endocrine diseases and endocrine-related tumors. Its lead product candidate is Paltusotine, an oral selective nonpeptide somatostatin receptor type 2 agonist that has completed phase III ...
More about CRNX
Track This Portfolio

Track Neos Investment Management LLC Portfolio

Follow Neos Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Neos Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Neos Investment Management LLC with notifications on news.